Finance

Lists
7ZT:FRA
Hamlet BioPharma AB
€0.40
0.00%
(0.00) 1D
Oct 8, 8:13:33 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 7ZT...
Avg. vol.
170.00
Volume
0.00
52-wk high
€0.83
52-wk low
€0.37
No. of employees
6
Avg. vol.
170.00
Volume
0.00
52-wk high
€0.83
52-wk low
€0.37
No. of employees
6
News stories
From web sources and news partners
About Hamlet BioPharma AB
CEOMartin Erixon | Mats Persson
Employees6
Founded2015
Headquarters-
SectorBiotechnology
Websitehamletbiopharma.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
52.93K
1.71K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.62M
13.01M
9.59M
13.34M
Operating expense
12.16M
15.58M
12.17M
15.94M
Total operating expenses
12.16M
15.58M
12.17M
15.94M
Operating income
-12.16M
-15.58M
-12.11M
-15.94M
Other non operating income
-1.00
1.00
-
-531.00
EBT including unusual items
-12.16M
-15.43M
-12.11M
-15.86M
EBT excluding unusual items
-12.16M
-15.43M
-12.11M
-15.86M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
7.87K
21.35K
23.53K
42.61K
Net income
-12.16M
-15.43M
-12.11M
-15.86M
Net profit margin
-
-
-22,880.16%
-926,578.21%
Earnings per share
-
-
-
-
Interest and investment income
2.41K
148.19K
2.65K
74.08K
Interest expense
-
-
-
-
Net interest expenses
2.41K
148.19K
2.65K
74.08K
Depreciation and amortization charges
2.54M
2.55M
2.55M
2.55M
EBITDA
-9.62M
-13.03M
-9.56M
-13.38M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps